View image online ( An uncapped GLP-1 injector on counter Ozempic, a once-weekly injectable medication used to help manage blood sugar levels for people living with Type 2 diabetes, may be one of the most talked-about medications in recent history
Clinical studies have shown that patients can achieve substantial weight loss, between 15% and 20% of body weight, when combined with lifestyle modifications
Your clinician can consider switching from semaglutide to another GLP-1 receptor agonist, adjusting titration, or adding targeted medications like prokinetics
The opioid epidemic is now dominated by illicitly manufactured fentanyl and death tolls continue to mount
Preclinical studies are needed to elucidate the underlying mechanisms
The results of supplementation depend on the athletes level, training program, diet, and dosage